These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29199671)

  • 1. Indian consensus statement for treatment of advanced non small cell lung cancer: First line, maintenance, and second line.
    ; ; ;
    Indian J Cancer; 2017; 54(1):89-103. PubMed ID: 29199671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line - Indian consensus statement update.
    Prabhash K
    South Asian J Cancer; 2019; 8(1):1-17. PubMed ID: 30766843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010.
    Felip E; Gridelli C; Baas P; Rosell R; Stahel R;
    Ann Oncol; 2011 Jul; 22(7):1507-1519. PubMed ID: 21536661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
    Soo RA; Anderson BO; Cho BC; Yang CH; Liao M; Lim WT; Goldstraw P; Mok TS;
    Lancet Oncol; 2009 Nov; 10(11):1102-10. PubMed ID: 19880064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A paradigm shift in the treatment of advanced non-small cell lung cancer.
    Varughese S; Jahangir KS; Simpson CE; Boulmay BC
    Am J Med Sci; 2012 Aug; 344(2):147-50. PubMed ID: 22317902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can a decisional algorithm be used in first-line treatment of advanced nonsmall cell lung cancer?
    Gridelli C
    Curr Opin Oncol; 2010 Mar; 22(2):77-8. PubMed ID: 20147784
    [No Abstract]   [Full Text] [Related]  

  • 7. Maintenance therapy: a new treatment paradigm in advanced nonsmall-cell lung cancer.
    Gridelli C
    Curr Opin Oncol; 2013 Mar; 25(2):105-6. PubMed ID: 23385858
    [No Abstract]   [Full Text] [Related]  

  • 8. [Impact of histology on efficacy of pemetrexed: pemetrexed in second-line setting and as maintenance therapy after first-line treatment in Chinese patients with advanced NSCLC].
    Zhou C; Wu Y; Sun Y; Wang Y; Wang X; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):29-33. PubMed ID: 24685083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer.
    Fidias P; Novello S
    J Clin Oncol; 2010 Dec; 28(34):5116-23. PubMed ID: 21041704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fourth-line and beyond therapy in advanced non-small cell lung cancer: a retrospective analysis].
    Wang X; Huang M; Ren L; Xu Y; Li L; Hou M; Wang J; Peng F; Zhu J; Wang Y; Lu Y
    Zhongguo Fei Ai Za Zhi; 2014 Dec; 17(12):839-44. PubMed ID: 25539608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer.
    Wu JY; Shih JY; Yang CH; Chen KY; Ho CC; Yu CJ; Yang PC
    Int J Cancer; 2010 Jan; 126(1):247-55. PubMed ID: 19536777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM).
    Facchinetti F; Pilotto S; Metro G; Baldini E; Bertolaccini L; Cappuzzo F; Delmonte A; Gasparini S; Inno A; Marchetti A; Passiglia F; Puma F; Ricardi U; Rossi A; Crinò L; Novello S
    Tumori; 2019 Jul; 105(5_suppl):3-14. PubMed ID: 31264531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced EGFR mutation-positive non-small-cell lung cancer: case report, literature review, and treatment recommendations.
    Kuykendall A; Chiappori A
    Cancer Control; 2014 Jan; 21(1):67-73. PubMed ID: 24357744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of stage III non-small cell lung cancer in India: An expert consensus statement.
    Batra U; Prabhash K; Agarwal JP; Darlong L; Munshi A; Penumadu P; Thangakunam B; Bansal A
    Asia Pac J Clin Oncol; 2023 Dec; 19(6):606-617. PubMed ID: 36815621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do U.S. medical oncologists learn and apply new clinical trials information from press releases in nonmedical media? A case study based on ECOG 4599.
    Dornbusch D; Allegra C; Willey J; Andrews M; Leff R; Epstein J; Jones J; Lokey L; Green MR
    Oncologist; 2006 Jan; 11(1):31-8. PubMed ID: 16401711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best practice in the treatment of advanced squamous cell lung cancer.
    Ang YL; Tan HL; Soo RA
    Ther Adv Respir Dis; 2015 Oct; 9(5):224-35. PubMed ID: 25902866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: a meta-analysis of randomized controlled clinical trials.
    Zhao N; Zhang XC; Yan HH; Yang JJ; Wu YL
    Lung Cancer; 2014 Jul; 85(1):66-73. PubMed ID: 24780111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Evolving Role of Nivolumab in Non-Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.
    Gridelli C; Besse B; Brahmer JR; Crinò L; Felip E; de Marinis F
    Clin Lung Cancer; 2016 May; 17(3):161-8. PubMed ID: 26908078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy.
    Kotake M; Miura Y; Imai H; Mori K; Sakurai R; Kaira K; Tomizawa Y; Minato K; Saito R; Hisada T
    Chemotherapy; 2017; 62(4):205-213. PubMed ID: 28380484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance chemotherapy for non-small-cell lung cancer.
    Kim YH; Mishima M
    Cancer Treat Rev; 2011 Nov; 37(7):505-10. PubMed ID: 21257270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.